期刊文献+

COPD患者血清TNF-α、IL-8及MMP-9的检测及临床意义 被引量:2

Levels of Serum TNF-α, IL-8 and MMP-9 in COPD Patients and Its Clinical Significance
下载PDF
导出
摘要 【目的】探讨慢性阻塞性肺疾病(COPD)患者血清中肿瘤坏死因子-α(TNF-α)、白细胞介素-8(IL-8)及基质金属蛋白酶-9(MMP-9)的含量变化及意义。【方法】抽取COPD急性期、缓解期患者及健康对照者静脉血,双抗夹心ELISA法检测血清中TNF-α、IL-8及MMP-9水平。【结果】C0PD急性期组TNF-α和IL-8水平显著高于缓解期及对照组;缓解期组IL-8水平显著高于对照组,急性期组及缓解期组MMP-9水平均显著高于对照组,以上差异均有显著性(P〈o.05)。【结论】TNF-α、IL-8及MMP-9参与了COPD的炎症过程,TNF-α及IL-8可在一定程度反映COPD患者病情变化及严重程度。 [Objective] To investigate the levels of serum TNF-α, IL-8 and MMP-9 in patients with chronic obstructive pulmonary disease(COPD) and to discuss the clinical significance. [Methods] Blood samples in patients with COPD both during acute exacerbation and stable stage were collected. Healthy volunteers were enrolled as controls. The levels of serum TNF-α, IL-8 and MMP-9 were measured by ELISA. [Results] The levels of TNF-α and IL-8 in patients with COPD during acute exacerbation were significantly higher than those in patients with COPD during stable stage and in the controls. The levels of IL-8 in patients with COPD during stable stage were significantly higher than those in the controls. The levels of MMP-9 in patients with COPD both during acute exacerbation and stable stage were significantly higher than those in the controls. [Conclusion]TNF-α, IL-8 and MMP-9 may take part in the inflammation activity of COPD. The levels of TNF-αand IL-8 may reflect the development and severity of COPD.
作者 周煦 赵飞
出处 《医学临床研究》 CAS 2009年第6期948-950,共3页 Journal of Clinical Research
关键词 肺疾病 阻塞性/A液 肿瘤坏死因子/血液 白细胞介素8/A液 金属蛋白酶类/血液 lung diseases,obstructive/BL tumor necrosis factor/BL metalloproteinases/BL
  • 相关文献

参考文献10

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1794
  • 2Victor Kim, Thomas J,Rogers,Gerard J. Criner. New concepts in the pathobiology of chronic obstructive pulmonary disease[J].Proc Am Thorac Soc , 2008,5 (4) : 478-485.
  • 3Fujita M, Shannon JM, Irvin CG,et al . Over expression of tumor necrosis faetor-alpha produces an increase in lung volumes and pulmonary hypertension[J]. Am J Physiol Lung Cell Mol Physiol , 2001,280 : L39-L49.
  • 4Churg A, Wang RD, Tai H, et al . Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse[J]. Am J Respir Crit Care Med ,2004,170:492-498.
  • 5侯静静,朱蕾.白介素-8与慢性阻塞性肺疾病[J].国外医学(呼吸系统分册),2005,25(6):427-429. 被引量:44
  • 6Gompertz S, O'Brien C, Bayley DL, et al . Changes in bronchial inflamonation during acute exacerbations of chronic bronchitis[J]. Fur Respir J , 2001,17 : 1112-1119.
  • 7Raulo SM, Sorsa T, Tervahartiala T, et al. MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar fluid(BALF) of COPD horses[J]. Equine Vet J , 2001,33 (2) : 128-136 : Comment in : 113-115.
  • 8Betsuyaku T, Nishimur M, Takeyabu K, et al. Neutrophil granule proteins in bronehoalveolar lavage fluid from subjects with subclinical emphysema [J]. Am J Respir Crit Care Med ,1999,159(6) :1985-1991.
  • 9Calikoglu M, Unlu A, Tamer L, et al . MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma[J].Tuberk Toraks , 2006,54 (2) : 114-21.
  • 10陆志伟,王伟,许仁和.慢性阻塞性肺疾病急性加重期患者近期预后的多因素分析[J].中国临床保健杂志,2008,11(1):21-23. 被引量:12

二级参考文献16

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2[2]De-la-Iglesia F,Valino P,Pita S.Factors predicting a hospital stay of over 3 days in patients with acute exacerbation of chronic obstructive pulmonary disease[J].J Intern Med,2002 ;251 (6):500-507.
  • 3[3]Cooper CB,Waterhouse J,Howard P.Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary therapy[J].Thorax,1987,42 (1):105-110.
  • 4[4]Bellone A,Spagnolatti L,Massobrio M,et al.Short-term effects of expiration under positive pressure in patientswith acute exacerbation of chronic obstructive pulmonary disease and mild acidosis requiring non-invasive positive pressure ventilation[J].Intensive Care Med,2002,28(5):581-585.
  • 5[6]Alsaeedi A,Sin DD,McAlister FA.The effects of inhaled corticosteroids in chronic obstructive pulmonary disease:a systematic review of randomized placebo-controlled trials[J].Am-J-Med,2002,113(1):59-65.
  • 6[7]Weitzenblum E,Sautegeau A,Ehrhart M,et al.Long term course of pulmonary arterial pressure in chronic obstructive pulmonary disease[J].Am Rev Respir Dis,1984,130(5):993-998.
  • 7冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 8GOLD Executive Committee[DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD,November 2006 [ 2006-11-18 ]. http://www.goldcopd.com/Guidelineitem. asp? 11 =2&12 = 1&intId =989.
  • 9Celli BR, MacNee W, Committee members. Standard for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.
  • 10Celli BR, Cote CG, Matin JM, et al. The body mass index,airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 2004,350 : 1005-1012.

共引文献1845

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部